Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial

BACKGROUND: Based on promising results from radiomic approaches to predict O(6)-methylguanine DNA methyltransferase promoter methylation status (MGMT status) and clinical outcome in patients with newly diagnosed glioblastoma, the current study aimed to evaluate radiomics in recurrent glioblastoma pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Autores principales: Vils, Alex, Bogowicz, Marta, Tanadini-Lang, Stephanie, Vuong, Diem, Saltybaeva, Natalia, Kraft, Johannes, Wirsching, Hans-Georg, Gramatzki, Dorothee, Wick, Wolfgang, Rushing, Elisabeth, Reifenberger, Guido, Guckenberger, Matthias, Weller, Michael, Andratschke, Nicolaus
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8079773/
https://ncbi.nlm.nih.gov/pubmed/33937035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.636672
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares